Urogen Pharma Ltd (URGN)
$32.72 -2.27% Close Oct 30, 2026 Live
Urogen Pharma stock today
Urogen Pharma closed at $32.72 on October 30, 2026, down 2.27% on the day. Over the past year it returned +64.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.59 billion.
$20.00$30.00$40.00$50.00
NovJan 2026MarMayJulSep
| Period | URGN | S&P 500 (SPY) |
|---|---|---|
| 1 month | -19.5% | -0.9% |
| 3 months | -20.4% | +2.1% |
| Year to date | +39.7% | +11.7% |
| 1 year | +64.8% | +12.4% |
| 3 years | +201.0% | +88.5% |
| 5 years | +90.2% | +76.0% |
Key statistics
- Market value
- $1.59B
- Forward P/E
- 28.0
- Price / sales
- 8.5
- 52-week range
- $17.00 to $50.29
- Next report
- Nov 4, 2026
About Urogen Pharma
Develops and commercializes treatments for urologic and gynecologic conditions.
Sector: Health Care
More on Urogen Pharma
- Financials: revenue, earnings and segmentsRevenue +21% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $1,902 today
No forecast, no recommendation. This page describes Urogen Pharma Ltd from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.